304 related articles for article (PubMed ID: 20143250)
21. Corticotropin-Releasing Factor (CRF) Neurocircuitry and Neuropharmacology in Alcohol Drinking.
Schreiber AL; Gilpin NW
Handb Exp Pharmacol; 2018; 248():435-471. PubMed ID: 29374836
[TBL] [Abstract][Full Text] [Related]
22. Corticotropin-releasing factor family and its receptors: pro-inflammatory or anti-inflammatory targets in the periphery?
Zhu H; Wang J; Li J; Li S
Inflamm Res; 2011 Aug; 60(8):715-21. PubMed ID: 21476084
[TBL] [Abstract][Full Text] [Related]
23. Corticotropin-releasing factor depolarizes rat lateral vestibular nuclear neurons through activation of CRF receptors 1 and 2.
Wang Y; Chen ZP; Yang ZQ; Zhang XY; Li JM; Wang JJ; Zhu JN
Neuropeptides; 2019 Aug; 76():101934. PubMed ID: 31130301
[TBL] [Abstract][Full Text] [Related]
24. The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27(Kip1) protein up-regulation and c-Myc mRNA down-regulation.
Pozzoli G; De Simone ML; Cantalupo E; Cenciarelli C; Lisi L; Boninsegna A; Dello Russo C; Sgambato A; Navarra P
Mol Cell Endocrinol; 2015 Sep; 412():205-15. PubMed ID: 25960164
[TBL] [Abstract][Full Text] [Related]
25. New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin-releasing factor.
Nemeroff CB
Neuropsychopharmacology; 1992 Feb; 6(2):69-75. PubMed ID: 1610487
[TBL] [Abstract][Full Text] [Related]
26. Acute stress and intravesical corticotropin-releasing hormone induces mast cell dependent vascular endothelial growth factor release from mouse bladder explants.
Cao J; Boucher W; Kempuraj D; Donelan JM; Theoharides TC
J Urol; 2006 Sep; 176(3):1208-13. PubMed ID: 16890727
[TBL] [Abstract][Full Text] [Related]
27. Corticotropin Releasing Factor promotes breast cancer cell motility and invasiveness.
Androulidaki A; Dermitzaki E; Venihaki M; Karagianni E; Rassouli O; Andreakou E; Stournaras C; Margioris AN; Tsatsanis C
Mol Cancer; 2009 Jun; 8():30. PubMed ID: 19490624
[TBL] [Abstract][Full Text] [Related]
28. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides.
Boorse GC; Denver RJ
Gen Comp Endocrinol; 2006 Mar; 146(1):9-18. PubMed ID: 16413023
[TBL] [Abstract][Full Text] [Related]
29. Corticotropin-releasing factor regulates the development in the direct developing frog, Eleutherodactylus coqui.
Kulkarni SS; Singamsetty S; Buchholz DR
Gen Comp Endocrinol; 2010 Dec; 169(3):225-30. PubMed ID: 20850439
[TBL] [Abstract][Full Text] [Related]
30. The corticotropin-releasing factor system as a potential target for antiobesity drugs.
Doyon C; Moraru A; Richard D
Drug News Perspect; 2004 Oct; 17(8):505-17. PubMed ID: 15605110
[TBL] [Abstract][Full Text] [Related]
31. The corticotropin-releasing factor system as a mediator of the appetite-suppressing effects of stress in fish.
Bernier NJ
Gen Comp Endocrinol; 2006 Mar; 146(1):45-55. PubMed ID: 16410007
[TBL] [Abstract][Full Text] [Related]
32. The role of corticotropin releasing factor in depressive illness: a critical review.
Mitchell AJ
Neurosci Biobehav Rev; 1998 Sep; 22(5):635-51. PubMed ID: 9662725
[TBL] [Abstract][Full Text] [Related]
33. Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart.
Yang LZ; Tovote P; Rayner M; Kockskämper J; Pieske B; Spiess J
Eur J Pharmacol; 2010 Apr; 632(1-3):1-6. PubMed ID: 20132811
[TBL] [Abstract][Full Text] [Related]
34. Corticotropin-releasing factor antagonists: recent advances and exciting prospects for the treatment of human diseases.
Gilligan PJ; Li YW
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):487-97. PubMed ID: 15338958
[TBL] [Abstract][Full Text] [Related]
35. Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin.
Arbiser JL; Karalis K; Viswanathan A; Koike C; Anand-Apte B; Flynn E; Zetter B; Majzoub JA
J Invest Dermatol; 1999 Nov; 113(5):838-42. PubMed ID: 10571742
[TBL] [Abstract][Full Text] [Related]
36. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.
Koob GF; Heinrichs SC
Brain Res; 1999 Nov; 848(1-2):141-52. PubMed ID: 10612706
[TBL] [Abstract][Full Text] [Related]
37. The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications.
Gravanis A; Margioris AN
Curr Med Chem; 2005; 12(13):1503-12. PubMed ID: 15974983
[TBL] [Abstract][Full Text] [Related]
38. Corticotrophin-releasing factor and stress-induced inhibition of the gonadotrophin-releasing hormone pulse generator in the female.
Li XF; Knox AM; O'Byrne KT
Brain Res; 2010 Dec; 1364():153-63. PubMed ID: 20727865
[TBL] [Abstract][Full Text] [Related]
39. Corticotropin-releasing factor (CRF) in stress and disease: a review of literature and treatment perspectives with special emphasis on psychiatric disorders.
Krohg K; Hageman I; Jørgensen MB
Nord J Psychiatry; 2008; 62(1):8-16. PubMed ID: 18389420
[TBL] [Abstract][Full Text] [Related]
40. Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system.
Bittencourt JC; Sawchenko PE
J Neurosci; 2000 Feb; 20(3):1142-56. PubMed ID: 10648719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
